These stories make new patients feel less isolated and provide authentic perspectives of what to expect
Furthermore, non-psychostimulants are associated with changes in cardiovascular parameters, cardiovascular events, somnolence, gastrointestinal tract symptoms, nausea, diarrhoea, vomiting, decreased appetite, fatigue, and dizziness [2,22]
Providers should track A1C, body weight, renal function, and gastrointestinal tolerance
According to available data on Bridge processing timelines, beneficiaries who arrive at the pharmacy with clear documentation of their eligibility pathway - the processor name, the diagnosis code, the BMI tier - move through the system significantly faster than those who rely on the pharmacy to sort it out
Dual action mechanism for more weight loss with less side effects